Orin Green Financial’s Protalix BioTherapeutics PLX Stock Holding History

Orin Green Financial’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.5K	Buy	10,675 +675	+7%	+$1.68K	0.01%	80
2026 Q2	$23.3K	Sell	10,000 -54,433	-84%	-$115K	0.01%	82
2026 Q1	$140K	Buy	64,433 +3,000	+5%	+$7.44K	0.06%	75
2025 Q4	$111K	Buy	61,433 +233	+0.4%	+$476	0.04%	73
2025 Q3	$136K	Hold	61,200	–	–	0.05%	83
2025 Q2	$90.6K	Buy	61,200 +11,200	+22%	+$22.9K	0.04%	76
2025 Q1	$128K	Buy	+50,000	New	+$119K	0.06%	72
2024 Q4	–	Sell	-72,000	Closed	-$102K	–	75
2024 Q3	$73.4K	Hold	72,000	–	–	0.03%	80
2024 Q2	$84.2K	Buy	+72,000	New	+$85.1K	0.04%	74
2024 Q1	–	Sell	-80,000	Closed	-$119K	–	76
2023 Q4	$142K	Hold	80,000	–	–	0.07%	74
2023 Q3	$133K	Buy	80,000 +19,850	+33%	+$35.6K	0.07%	67
2023 Q2	$120K	Buy	+60,150	New	+$143K	0.06%	67

Other funds holding PLX

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

CPA

Capital Performance Advisors Walnut Creek, California $1.65B AUM 15.94% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Orin Green Financial's PLX Position: Q3 2026 in Review

Orin Green Financial increased its Protalix BioTherapeutics (PLX) stake by 6.8% in Q3 2026, buying an estimated $1.68K and bringing the position to 10,675 shares worth $29.5K. The position accounts for 0.01% of the portfolio, ranked #80.

Orin Green Financial first reported a position in PLX in Q2 2023 and has held it in 12 quarters since. The position peaked at $142K in Q4 2023. 32 funds tracked by Wall St. Rank hold PLX as of Q3 2026.

Orin Green Financial held 10,675 shares of Protalix BioTherapeutics worth $29.5K as of Q3 2026.
Orin Green Financial bought 675 Protalix BioTherapeutics shares in Q3 2026, an estimated $1.68K.
Protalix BioTherapeutics made up 0.01% of Orin Green Financial's portfolio in Q3 2026, its #80 holding.
Orin Green Financial first reported a position in Protalix BioTherapeutics in Q2 2023 and has held it in 12 quarters since.
Orin Green Financial's Protalix BioTherapeutics position peaked at $142K in Q4 2023.
32 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q3 2026.

Based on Orin Green Financial's 13F filing for Q3 2026, filed 19 Oct 2026.